Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ABAX

Abaxis (ABAX) Stock Price, News & Analysis

Abaxis logo

About Abaxis Stock (NASDAQ:ABAX)

Advanced Chart

Key Stats

Today's Range
$83.00
$83.00
50-Day Range
N/A
52-Week Range
$43.66
$83.98
Volume
N/A
Average Volume
167,754 shs
Market Capitalization
N/A
P/E Ratio
42.35
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care to provide rapid blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan profiles, which are packaged as single-use plastic veterinary reagent discs; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results; VetScan UA, a urinalysis solution; and VetScan SA, which is designed to perform urine microscopy. Further, it provides VetScan rapid tests for the detection of various diseases, as well as sells products developed through its patented Orbos discrete lyophilization process to companies for other applications. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.

Receive ABAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abaxis and its competitors with MarketBeat's FREE daily newsletter.

ABAX Stock News Headlines

Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks.
See More Headlines

ABAX Stock Analysis - Frequently Asked Questions

Abaxis, Inc. (NASDAQ:ABAX) posted its quarterly earnings data on Thursday, April, 26th. The medical research company reported $0.42 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.32 by $0.10. Abaxis's revenue was up 16.7% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Abaxis investors own include Skyworks Solutions (SWKS), Wells Fargo & Company (WFC), Bristol-Myers Squibb (BMY), Abbott Laboratories (ABT), Allergan (AGN), Akorn (AKRX) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
4/26/2018
Today
6/04/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Measuring & Controlling Devices
Sub-Industry
Health Care Equipment
Current Symbol
NASDAQ:ABAX
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
42.35
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ABAX) was last updated on 6/4/2025 by MarketBeat.com Staff
From Our Partners